Share Name Share Symbol Market Type Share ISIN Share Description
Croda International Plc LSE:CRDA London Ordinary Share GB00BJFFLV09 ORD 10.609756P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -30.00 -0.59% 5,070.00 5,075.00 5,085.00 5,130.00 5,075.00 5,090.00 260,210 16:35:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 1,386.9 317.8 181.4 27.9 6,682

Croda Share Discussion Threads

Showing 151 to 174 of 575 messages
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
22/1/2009
12:24
free stock charts from www.advfn.com
jonnyfro
21/1/2009
13:01
Some big buying today at these low prices. Stocking up before the results out on 17th Feb perhaps ?
garethcoulson
16/1/2009
13:58
You were saying ?
garethcoulson
16/1/2009
10:28
Here comes the reversal as predicted...
jonnyfro
15/1/2009
12:30
At least. £5K more for me yesterday so £6 will do nicely.
garethcoulson
15/1/2009
12:10
a bottom here of £4.50 ish then a rise up to £6
jonnyfro
15/1/2009
10:36
And from thay you predict what ?
garethcoulson
15/1/2009
10:26
Looks to me like an inverse head and shoulders formation
jonnyfro
14/1/2009
12:38
Bit of a copy and paste of the last one they did but updtaed and still a buy. More for me today at £4.65
garethcoulson
14/1/2009
12:33
GC, Croda 497¼p –7¾p Questor says BUY Shares in specialist chemicals group Croda have added 28pc since Questor recommended the company as a good defensive play on December 8 – but there could be more gains to come. Despite the recent rally, Questor remains cautious about global markets – and still favours a defensive core strategy with some exposure to deleveraging. The earnings season kicked off after the US market closed on Monday, with aluminium giant Alcoa, but next week sees numbers from banking giants Citigroup and Bank of America, which are expected to be grim. There could be downside risk to markets on both sides of the Atlantic as company after company confesses to a dire performance in the last three months of 2008. Some commentators and analysts are more confident: on Monday, Credit Suisse said in a note to clients that there was a 55pc chance that November last year saw the low in equity markets. However, it did concede that we would not see a normal bull market until the structural issues of deleveraging were more complete. The broker also said that, if this was merely a bear market rally, it still saw another 10pc-20pc of upside. Credit Suisse pointed out that, in Japan in the 1990s, there were three bear market rallies, with each producing gains of 50pc-60pc. Questor suspects the bear is not quite dead yet – and believes that shares in Croda are still a defensive buy. The group manufactures chemicals for the health care sector, the cosmetic industry and crop care products that are used in herbicides and insecticides. Its other products include lubricants for the oil and gas industry, solutions to help in textile processing and polymers for plastics and packaging, plus many more. Significantly, the company itself owns the intellectual property for a large number of its formulations. It also supplies ingredients for the high-end cosmetics sold by luxury brands such as Chanel and Estée Lauder. "We appeal to two things that will never go away – vanity and ageing," Croda chief executive Mike Humphrey said after its last results statement. Around 90pc of group earnings come from its consumer care operations, mostly low-ticket defensive items. Its industrial products cover a wide range of sectors, which should provide some earnings protection – although total volumes are likely to fall. The currency markets have also moved in the company's favour – so this should help boost full-year numbers, which are expected to be released on February 17. The UK contributes less than 10pc to total sales, with around 50pc coming from Europe and 25pc from the Americas. The group is also very cash generative, with free cash flow in the first half of 2008 jumping to £63.9m – 132pc ahead of the first half of 2007. Questor also likes dividends – and Croda's payout looks pretty secure. With the company ticking all the right investment boxes, Croda shares are a buy, despite the rally in the stock since Questor first recommended a long position. The shares have come off their recent high of 558½p, so now looks like a good time to enter into a position.
kilgallp
14/1/2009
12:26
GC, I have a paper copy, I'll see if I can find it on-line. PK
kilgallp
14/1/2009
10:49
You got the Questor tip Kilgallp ?
garethcoulson
14/1/2009
10:27
These were again tipped by Questor this week, and were a Shares mag tip for 2009. Just added some of these to my ISA.
kilgallp
08/1/2009
18:07
£0.3M buy at close - not the kind of money you take a punt with
garethcoulson
30/12/2008
13:02
DIRTECTOR BUYING AT £5.02 - GREAT NEWS.
garethcoulson
29/12/2008
17:37
Thanks for that !
garethcoulson
29/12/2008
16:37
What a recovery ! Now all the way back to £7 in Q1 09 !
garethcoulson
23/12/2008
09:29
Should have sold the wife to buy these at £3.80 !!!
garethcoulson
22/12/2008
18:51
Good recovery taking place - long may it continue!
plentymorefish
09/12/2008
18:26
garethcoulson - thanks for posting that. Nice to be reminded the value in this one, I'm in at 508 so still someway to go before breakeven but I consider this a solid long term hold.
plentymorefish
09/12/2008
09:28
Croda has the right elements to enable it to flourish By Garry White Last Updated: 8:47PM GMT 08 Dec 2008 Croda International 389¾p +10 Questor says BUY Good companies as well as bad companies have seen their share price hammered over the last year. Today I want to highlight one of the good ones. Croda International is a world leader in the manufacture of speciality chemicals. It is likely to see some hit from the parlous state of the global economy, but Questor still regards it as a defensive business. The shares have fallen 46pc from their peak on May 5 2008 and Questor believes that this has created an opportunity to get in ahead of a strong set of full-year numbers. The group manufactures chemicals for the healthcare businesses, the cosmetic industry and crop care products that are used in herbicides and insecticides. Its other products include lubricants for the oil and gas industry, solutions to help in textile processing and polymers for plastics and packaging, plus many, many more. It also supplies ingredients for the high-end cosmetics sold by luxury brands such as Chanel and Estée Lauder. "We appeal to two things that will never go away – vanity and ageing," Croda chief executive Mike Humphrey said after its last results statement. Around 75pc of group earnings come from its consumer care operations, mostly low-ticket defensive items. Its industrial products cover a wide range of sectors, which should provide some earnings protection next year – although total volumes are likely to fall. The latest full earnings statement covers the six-month period to June 30 2008. Despite the cost inflation in this period, the company managed to post an increase in pre-tax profits of 64.1pc. When the performance of discontinued businesses is stripped out, pre-tax profits actually jumped a stunning 90.3pc. There was a one-off spike in glycerine prices, which flattered the results in the period. The spike provided an additional £4.9m to earnings, constituting just over 9pc of total profits in the period. The disposal of non-core businesses has also reduced net debt, which stood at £364.7m at the end of September. Disposals in the first half included the sale of Baxenden Chemicals in February 2008 to Chemtura for £13m and its Chicago Oleochemical business was sold to HIG Capital in May 2008 for £45.1m. The company managed to fully recover the cost of increased raw materials prices in the first half. However, input costs are now likely to move lower, which should help to boost margins. Of course, customers will be demanding that these cost savings are passed on, but Questor expects that the company will not transfer 100pc of the reduction, which should provide a cushion from falling volumes. The currency markets are also moving in the company's favour – so this should help boost full-year numbers, which are expected to be released in February 2009. So far this year, sales and earnings have been boosted by around 10pc by currency movements. Collins Stewart has calculated that if exchange rates stayed at their current rate, earning in 2009 could see a 15pc boost. However, Questor expects that the pound may slide further in the next six months – providing an even greater currency-related gain. The UK contributes less than 10pc to total sales, with around 50pc coming from Europe and 25pc from the Americas. The company's latest trading update was issued at the start of November – and management oozed confidence. It said global demand for its core products remained robust, with the personal care and crop care sectors showing strong growth. For the three months ended September 30 2008, sales excluding disposals were £246.7m, up 25.2pc from the corresponding period last year. Pre-tax profit on the same basis was 73.2pc higher at £24.6m due to sales increase, synergies realised from the acquisition of Uniqema, favourable currency translation and a reduced interest charge. Croda bought Uniqema from ICI in September 2006 and it is still generating synergies from the complimentary businesses. The company also said that, on a constant currency basis, Croda's average selling price per tonne increased 20.5pc year on year. This reflects not only price increases but also favourable mix from shedding low-quality businesses and the higher sales value of the turnover formerly carried out by third-party distributors. In the year to December 30 2008, pre-tax profits are expected to jump 61pc to £98.13m and earnings per share are forecast to rise 23pc to 48p. This leaves the shares trading on a current-year forward multiple of just 8 times. This looks far too low. This is exactly the type of company that Questor is looking for. The board has proved its effectiveness at cost management and the group is well diversified in different markets – from personal care to oil and gas products to crop management. The group generates more than 90pc of its sales abroad, so it will see benefits from a weak pound. The group is also very cash generative, with free cash flow in the first half of 2008 jumping to £63.9m – 132pc ahead of the first half of 2007. Questor also likes dividends – and Croda's pay-out looks pretty secure. In 2007, its dividend cover on continuing operations was more than two times. The full-year pay-out for 2008 expected to rise to 18.9p from 15.75p last year, which implies a healthy dividend yield of 4.8pc. Even if there was no increase in the dividend, the shares are still yielding 4pc. With the company ticking all the right investment boxes, Croda shares are a definite buy.
garethcoulson
09/12/2008
09:19
From Todays Questor column in the Telegraph http://www.telegraph.co.uk/finance/markets/questor/3685822/Croda-has-the-right-elements-to-enable-it-to-flourish.html
gorilla36
07/12/2008
19:17
Well my initial purchase early Nov quite a bit underwater - so much for MIDAS tips. Still, twas only a small dabble so will just forget about them for now & next time I look I may be pleasantly surprised, or maybe I should buy some more but averaging down doesn't often work for me!
plentymorefish
05/12/2008
19:36
garethcoulson - ssshh, lets keep quiet as the longer we can keep accumulating at these prices the more we'll make when the recovery starts! good luck!
hazardaguess
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1
Your Recent History
LSE
CRDA
Croda
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200123 02:25:59